TP53 and small cell lung carcinoma: With adjusted P‐value < 0.05, seven pathways were enriched by the 10 DEGs (Figure 5D), many of which were tumour‐associated pathways, including the ‘Bladder cancer’, and the ‘p53 signalling pathway’ and the ‘Small cell lung cancer’.